77 related articles for article (PubMed ID: 23060550)
1. Cytostatic activity of a 5-fluoro-2'-deoxyuridine-alendronate conjugate against gastric adenocarcinoma and non-malignant intestinal and fibroblast cell lines.
Weinreich J; Schott TC; Königsrainer I; Küper M; Königsrainer A; Schott H
Anticancer Res; 2012 Oct; 32(10):4299-305. PubMed ID: 23060550
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo toxicity of 5-FdU-alendronate, a novel cytotoxic bone-seeking duplex drug against bone metastasis.
Schott S; Vallet S; Tower RJ; Noor S; Tiwari S; Schem C; Busch C
Invest New Drugs; 2015 Aug; 33(4):816-26. PubMed ID: 25986684
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5-Fluorodeoxyuridine-Alendronate in a Preclinical Model of Breast Cancer Bone Metastases.
Schem C; Tower RJ; Kneissl P; Rambow AC; Campbell GM; Desel C; Damm T; Heilmann T; Fuchs S; Zuhayra M; Trauzold A; Glüer CC; Schott S; Tiwari S
J Bone Miner Res; 2017 Mar; 32(3):536-548. PubMed ID: 27714838
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of gastric adenocarcinoma and normal cell lines against combined or conjugated antimetabolites.
Weinreich J; Struller F; Küper M; Hack A; Königsrainer A; Schott TC
Anticancer Drugs; 2013 Apr; 24(4):375-83. PubMed ID: 23358120
[TBL] [Abstract][Full Text] [Related]
5. N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).
Schott H; Goltz D; Schott TC; Jauch C; Schwendener RA
Bioorg Med Chem; 2011 Jun; 19(11):3520-6. PubMed ID: 21536448
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay.
Schott S; Wallwiener M; Kootz B; Seeger H; Fehm T; Neubauer H
Invest New Drugs; 2012 Aug; 30(4):1750-5. PubMed ID: 21604021
[No Abstract] [Full Text] [Related]
7. [Antisense oligonucleotides with antitumor activity].
Otvös L; Sági G
Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
[TBL] [Abstract][Full Text] [Related]
8. Growth and Chemosensitivity of Gastric Adenocarcinoma and Non-Malignant Cell Lines in Response to Novel Anti-Cancer Drug Combinations.
Weinreich J; Archid R; Bajaeifer K; Hack A; Königsrainer A; Schott TC
Chemotherapy; 2014; 60(5-6):346-52. PubMed ID: 26314695
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
[TBL] [Abstract][Full Text] [Related]
10. Cytostatic activity of the duplex drug linking 2'-deoxy-5-fluorouridine (5FdU) with 3'-C-ethynylcytidine (ECyd) against gastric adenocarcinoma cell lines.
Weinreich J; Schott S; Königsrainer I; Zieker D; Königsrainer A; Schott H
Invest New Drugs; 2011 Dec; 29(6):1294-302. PubMed ID: 20596746
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of scirrhous gastric cancer to 5-fluorouracil and the role of cancer cell-stromal fibroblast interaction.
Nakajima K; Okita Y; Matsuda S
Oncol Rep; 2004 Jul; 12(1):85-90. PubMed ID: 15201964
[TBL] [Abstract][Full Text] [Related]
12. Low concentrations of alendronate increase the local invasive potential of osteoblastic sarcoma cell lines via connexin 43 activation.
Yoshitani K; Kido A; Honoki K; Akahane M; Fujii H; Tanaka Y
Pathol Res Pract; 2011 Jul; 207(7):417-22. PubMed ID: 21665377
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activities of amphiphilic 5-fluoro-2'-deoxyuridylic acid prodrugs.
Ludwig PS; Schwendener RA; Schott H
Eur J Med Chem; 2005 May; 40(5):494-504. PubMed ID: 15893023
[TBL] [Abstract][Full Text] [Related]
14. [Experimental chemotherapy of human gastric cancer cell lines in vitro and in nude mice].
Pan XY; Li FQ; Yu RJ; Xie GF; Wang H; Zhao LY; Zhang Q
Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):15-8. PubMed ID: 2843330
[TBL] [Abstract][Full Text] [Related]
15. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
[TBL] [Abstract][Full Text] [Related]
16. [Effect of human epidermal factor (hEGF) on antitumor activity of 5-fluorouracil (5-FU) in human gastric cancer cell lines].
Saito D; Yoshida S; Okazaki N; Ohkura H
Gan To Kagaku Ryoho; 1989 May; 16(5):2117-20. PubMed ID: 2543331
[No Abstract] [Full Text] [Related]
17. RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase.
Lee KH; Hur HS; Im SA; Lee J; Kim HP; Yoon YK; Han SW; Song SH; Oh DY; Kim TY; Bang YJ
Cancer Lett; 2010 Dec; 299(1):22-8. PubMed ID: 20727673
[TBL] [Abstract][Full Text] [Related]
18. Brief tamoxifen pretreatment enhances the chemosensitivity of gastric carcinoma cells to 5-fluorouracil in vitro.
Koullias GJ; Pratsinis CI; Korkolis DP; Kouraklis G; Papadopoulos SA; Davaris PS; Golematis BCh
Anticancer Res; 2003; 23(2B):1575-80. PubMed ID: 12820425
[TBL] [Abstract][Full Text] [Related]
19. Calpain regulates thymidylate synthase-5-fluoro-dUMP complex levels associated with response to 5-fluorouracil in gastric cancer cells.
Nabeya Y; Suzuki T; Furuya A; Koide N; Ohkoshi M; Takiguchi M; Ochiai T; Matsubara H; Hiwasa T
Cancer Sci; 2011 Aug; 102(8):1509-15. PubMed ID: 21561529
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro activities of new anticancer duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) via a phosphodiester bonding.
Schott H; Schott S; Schwendener RA
Bioorg Med Chem; 2009 Oct; 17(19):6824-31. PubMed ID: 19744858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
